442
Views
7
CrossRef citations to date
0
Altmetric
Clinical Features - Review

A review and critique of published real-world weight management program studies

Pages 548-560 | Received 23 May 2018, Accepted 05 Jul 2018, Published online: 11 Aug 2018

References

  • World Health Organization (WHO). 2015a. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/ (Accessed 2017 Jan).
  • Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–814.
  • Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):755–781.
  • Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(7):842–884.
  • Finkelstein, TJG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28:w822–w831.
  • Cawley J, Meyerhoefer C, Biener A, et al. Savings in medical expenditures associated with reductions in body mass index among US adults with obesity, by diabetes status. Pharmacoeconomics. 2015;33:707–722.
  • Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
  • Tuomilehto H, Seppa J, Uusitupa M. Obesity and obstructive sleep apnea—clinical significance of weight loss. Sleep Med Rev. 2013;17:321–329.
  • Chen LL, Wang X, Wang J, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev. 2013;22:1395–1408.
  • El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307–2312.
  • Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–1231.
  • Karlas T, Wiegand J, Berg T. Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae. Best Pract Res Clin Endocrinol Metab. 2013;27:195–208.
  • Cuspidi C, Rescaldani M, Sala C, et al. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2014;32:16–25.
  • Abed HS, Wittert GA. Obesity and Atrial Fibrillation. Obes Rev. 2013;14:929–938.
  • Chandra Neeland IJ, Berry JD. The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study. J Am Coll Cardiol. 2014;64:997–1002.
  • McGowen C, Birerdinc A, Younossi ZM. Adipose tissue as an endocrine organ. Clin Liver Dis. 2014;18:41–58.
  • Díaz-Redondo, Giráldez-García C, Carrillo L, et al. Modifiable risk factors associated with prediabetes in men and women: a cross-sectional analysis of the cohort study in primary health care on the evolution of patients with prediabetes (PREDAPS-Study). BMC Fam Pract. 2015;16:5.
  • Poirier, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898–918.
  • Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care. 2000;23:1278–1283.
  • Bliddal H, Leeds AR, Christensen R. Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons – a scoping review. Obes Rev. 2014;15:578–586.
  • Zhou ZY, Liu YK, Chen HL, et al. Body mass index and knee osteoarthritis risk: a dose-response meta-analysis. Obesity (Silver Spring). 2014;22:2180–2185.
  • Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211–2219.
  • Bays HE, Seger JC, Primack C, et al. Obesity Algorithm, presented by the Obesity Medicine Association. Available from: www.obesityalgorithm.org. 2016–2017. (Accessed 2017 Dec 4).
  • American Board of Obesity Medicine. Available from: www.abom.org. (Accessed 2018 May 32).
  • Brand-Miller J, McMillan-Price J, Steinbeck K, et al. Carbohydrates–the good, the bad and the whole grain. Asia Pac J Clin Nutr. 2008;17(Suppl 1):16–19.
  • Chao HL. Body image change in obese and overweight persons enrolled in weight loss intervention programs: a systematic review and meta-analysis. PLoS One. 2015;10(5):e0124036.
  • Du H, Feskens E. Dietary determinants of obesity. Acta Cardiol. 2010;65(4):377–386.
  • Egberts K, Brown WA, Brennan L, et al. Does exercise improve weight loss after bariatric surgery? A systematic review. Obes Surg. 2012;22(2):335–341.
  • Gudzune KA, Doshi RS, Mehta AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162(7):501–512.
  • Hu T, Bazzano LA. The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies. Nutr Metab Cardiovasc Dis. 2014;24(4):337–343.
  • Jacobi D, Ciangura C, Couet C, et al. Physical activity and weight loss following bariatric surgery. Obes Rev. 2011;12(5):366–377.
  • Leggatt-Cook C, Chamberlain K. Blogging for weight loss: personal accountability, writing selves, and the weight-loss blogosphere. Sociol Health Illn. 2012;34(7):963–977.
  • Ma Y, Pagoto SL, Griffith JA, et al. A dietary quality comparison of popular weight-loss plans. J Am Diet Assoc. 2007;107(10):1786–1791.
  • Maher CA, Lewis LK, Ferrar K, et al. Are health behavior change interventions that use online social networks effective? A systematic review. J Med Internet Res. 2014;16(2):e40.
  • Mehta AK, Doshi RS, Chaudhry ZW, et al. Benefits of commercial weight-loss programs on blood pressure and lipids: a systematic review. Prev Med. 2016;90:86–99.
  • Mitchell NS, Prochazka AV, Glasgow RE. Time to RE-AIM: why community weight loss programs should be included in academic obesity research. Prev Chronic Dis. 2016;13:E37.
  • Olson KL, Emery CF. Mindfulness and weight loss: a systematic review. Psychosom Med. 2015;77(1):59–67.
  • Porter Starr KN, Bales CW. Excessive Body Weight in Older Adults. Clin Geriatr Med. 2015;31(3):311–326.
  • Raaijmakers LC, Pouwels S, Berghuis KA, et al. Technology-based interventions in the treatment of overweight and obesity: a systematic review. Appetite. 2015;95:138–151.
  • Roberts JR. The paradox of artificial sweeteners in managing obesity. Curr Gastroenterol Rep. 2015;17(1):423.
  • Robertson C, Archibald D, Avenell A, et al. Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men. Health Technol Assess. 2014;18(35):1–424.
  • Stehr MD, Von Lengerke T. Preventing weight gain through exercise and physical activity in the elderly: a systematic review. Maturitas. 2012;72(1):13–22.
  • Vakil RM, Doshi RS, Mehta AK, et al. Direct comparisons of commercial weight-loss programs on weight, waist circumference, and blood pressure: a systematic review. BMC Public Health. 2016;16:460.
  • Weinstein PK. A review of weight loss programs delivered via the Internet. J Cardiovasc Nurs. 2006;21(4):251–258.
  • McEvedy SM, Sullivan-Mort G, McLean SA, et al. Ineffectiveness of commercial weight-loss programs for achieving modest but meaningful weight loss: systematic review and meta-analysis. J Health Psychol. 2017;22(12):1614–1627.
  • Vakil RM, Chaudhry ZW, Doshi RS, et al. Commercial Programs’ Online Weight-Loss Claims Compared to Results from Randomized Controlled Trials. Obesity. 2017;25(11):1885–1893.
  • West DS, Coulon SM, Monroe CM, et al. Evidence-Based Lifestyle Interventions for Obesity and Type 2 Diabetes: the Look AHEAD Intensive Lifestyle Intervention as Exemplar. Am Psychol. 2016;71(7):614–627.
  • Longin R, Grasse M, Aspalter R, et al. Effectiveness of the online weight reduction program KiloCoach and comparison with other evaluated commercial direct intervention and online programs. Obes Facts. 2012;5(3):372–383.
  • Hayes MR, Miller CK, Ulbrecht JS, et al. A carbohydrate-restricted diet alters gut peptides and adiposity signals in men and women with metabolic syndrome. J Nutr. 2007;137(8):1944–1950.
  • Moosheer SM, Waldschutz W, Itariu BK, et al. A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Prim Care Diabetes. 2014;8(4):308–314.
  • Paoli A, Bianco A, Grimaldi KA, et al. Long term successful weight loss with a combination biphasic ketogenic Mediterranean diet and Mediterranean diet maintenance protocol. Nutrients. 2013;5(12):5205–5217.
  • Sarter B, Campbell TC, Fuhrman J. Effect of a high nutrient density diet on long-term weight loss: a retrospective chart review. Altern Ther Health Med. 2008;14(3):48–53.
  • Poulsen SK, Crone C, Astrup A, et al. Long-term adherence to the New Nordic Diet and the effects on body weight, anthropometry and blood pressure: a 12-month follow-up study. Eur J Nutr. 2015;54(1):67–76.
  • Tol J, Swinkels IC, de Bakker DH, et al. Dietetic treatment lowers body mass index in overweight patients: an observational study in primary health care. J Hum Nutr Diet. 2014;27(5):426–433.
  • Torres MR, Ferreira Tda S, Nogueira Lde P, et al. Dietary counseling on long-term weight loss in overweight hypertensive patients. Clinics (Sao Paulo). 2011;66(10):1779–1785.
  • Meffert C, Gerdes N. Program adherence and effectiveness of a commercial nutrition program: the metabolic balance study. J Nutr Metab. 2010;2010:197656.
  • Coleman CD, Kiel JR, Mitola AH, et al. Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study. Nutr J. 2015;14:77.
  • Mitchell NS, Ellison MC, Hill JO, et al. Evaluation of the effectiveness of making Weight Watchers available to Tennessee Medicaid (TennCare) recipients. J Gen Intern Med. 2013;28(1):42711.
  • Piatt GA, Seidel MC, Powell RO, et al. Comparative effectiveness of lifestyle intervention efforts in the community: results of the Rethinking Eating and ACTivity (REACT) study. Diabetes Care. 2013;36(2):202–209.
  • Held M, Mittnacht M, Kolb M, et al. Pulmonary and cardiac function in asymptomatic obese subjects and changes following a structured weight reduction program: a prospective observational study. PLoS One. 2014;9(9):e107480.
  • Wright G, Dawson B, Jalleh G, et al. Impact of compliance on weight loss and health profile in a very low energy diet program. Aust Fam Physician. 2010;39:49–52.
  • Bruno M, Touger-Decker R, Byham-Gray L, et al. Workplace weight loss program: impact on quality of life. J Occup Environ Med. 2011;53(12):1396–1403.
  • Dalen J, Smith BW, Shelley BM, et al. Pilot study: mindful Eating and Living (MEAL): weight, eating behavior, and psychological outcomes associated with a mindfulness-based intervention for people with obesity. Complement Ther Med. 2010;18(6):260–264.
  • Kidd LI, Graor CH, Murrock CJ. A mindful eating group intervention for obese women: a mixed methods feasibility study. Arch Psychiatr Nurs. 2013;27(5):211–218.
  • Karlsen K, Humaidan P, Sorensen LH, et al. Motivational interviewing: a part of the weight loss program for overweight and obese women prior to fertility treatment. Gynecol Endocrinol. 2013;29(9):839–842.
  • National Cancer Institute, NCI Dictionary of cancer terms. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=775080. (Accessed 2017 Oct 12).
  • U.S. Preventive Services Task Force. Draft Recommendation Statement: weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: behavioral Interventions. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/obesity-in-adults-interventions (Accessed 2018 Mar 14).
  • Lyon MR, Reichert RG. The effect of a novel viscous polysaccharide along with lifestyle changes on short-term weight loss and associated risk factors in overweight and obese adults: an observational retrospective clinical program analysis. Altern Med Rev. 2010;15(1):68–75.
  • Copaci I, Lupescu I, Caceaune E, et al. Noninvasive Markers of Improvement of Liver Steatosis Achieved by Weight Reduction in Patients with Nonalcoholic Fatty Liver Disease. Rom J Intern Med. 2015;53(1):54–62.
  • Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2017;65(4):1293–1305.
  • Rothberg AE, McEwen LN, Fraser T, et al. The impact of a managed care obesity intervention on clinical outcomes and costs: a prospective observational study. Obesity (Silver Spring). 2013;21(11):2157–2162.
  • Garies S, Irving A, Williamson T, et al. Using EMR data to evaluate a physician-developed lifestyle plan for obese patients in primary care. Can Fam Physician. 2015;61(5):e225–e231.
  • Dixon KJ, Shcherba S, Kipping RR. Weight loss from three commercial providers of NHS primary care slimming on referral in North Somerset: service evaluation. J Public Health (Oxf). 2012;34(4):555–561.
  • Ahern AL, Olson AD, Aston LM, et al. Weight Watchers on prescription: an observational study of weight change among adults referred to Weight Watchers by the NHS. BMC Public Health. 2011;11:434.
  • Minneboo M, Peters RJ, Miller-Kovach K, et al. Referral to a commercial weight management program in patients with coronary heart disease: a pilot study in the Netherlands. J Cardiopulm Rehabil Prev. 2015;35(4):268–271.
  • Ekman MJ, Klintenberg M, Bjorck U, et al. Six-minute walk test before and after a weight reduction program in obese subjects. Obesity (Silver Spring). 2013;21(3):E236–e243.
  • Bush J, Langley C, Mills S, et al. A comparison of the provision of the My Choice Weight Management Programme via general practitioner practices and community pharmacies in the United Kingdom. Clin Obes. 2014;4(2):91–100.
  • Gondoni LA, Titon AM, Nibbio F, et al. Short-term effects of a hypocaloric diet and a physical activity programme on weight loss and exercise capacity in obese subjects with chronic ischaemic heart disease: a study in everyday practice. Acta Cardiol. 2008;63(2):153–159.
  • Wanjek M, Senner V, Scharhag-Rosenberger F, et al. Effects of different weight loss intervention programmes in health clubs - an observational multicenter study. Eur J Sport Sci. 2016;16(7):859–867.
  • DeMaria A, DeMaria C, Demaria R, et al. A weight loss program in a chiropractic practice: a retrospective analysis. Complement Ther Clin Pract. 2014;20(2):125–129.
  • Davis J, Clark B, Lewis G, et al. The impact of a worksite weight management program on obesity: a retrospective analysis. Popul Health Manag. 2014;17(5):265–271.
  • Goetzel RZ, Roemer EC, Pei X, et al. Second-Year results of an Obesity Prevention Program at The Dow Chemical Company. J Occup Environ Med. 2010;52(3):291–302.
  • Mao AY, Chen C, Magana C, et al. A mobile phone-based health coaching Intervention for weight loss and blood pressure reduction in a national payer population: a retrospective study. JMIR Mhealth Uhealth. 2017;5(6):e80.
  • Rolland C, Johnston KL, Lula S, et al. Long-term weight loss maintenance and management following a VLCD: a 3-year outcome. Int J Clin Pract. 2014;68(3):379–387.
  • Coleman CD, Kiel JR, Mitola AH, et al. Comparative effectiveness of a portion-controlled meal replacement program for weight loss in adults with and without diabetes/high blood sugar. Nutr Diabetes. 2017;7(7):e284.
  • McLean RC, Morrison DS, Shearer R, et al. Attrition and weight loss outcomes for patients with complex obesity, anxiety and depression attending a weight management programme with targeted psychological treatment. Clin Obes. 2016;6(2):133–142.
  • Porsdal V, Beal C, Kleivenes OK, et al. The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders. BMC Psychiatry. 2010;10:42.
  • Haas WC, Moore JB, Kaplan M, et al. Outcomes from a medical weight loss program: primary care clinics versus weight loss clinics. Am J Med. 2012;125(6):603.e7–603.e11.
  • Nordstrand N, Gjevestad E, Hertel JK, et al. Arterial stiffness, lifestyle intervention and a low-calorie diet in morbidly obese patients-a nonrandomized clinical trial. Obesity (Silver Spring). 2013;21(4):690–697.
  • Dandanell S, Ritz C, Verdich E, et al. Repeated lifestyle interventions lead to progressive weight loss: a retrospective review chart study. Scand J Public Health. 2017;45(3):305–313.
  • Gin H, Demeaux JL, Grelaud A, et al. Observation of the long-term effects of lifestyle intervention during balneotherapy in metabolic syndrome. Therapie. 2013;68(3):163–167.
  • Christiansen T, Bruun JM, Madsen EL, et al. Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow-up. Obesity (Silver Spring). 2007;15(2):413–420.
  • Chen EY, Olino TM, Conklin CJ, et al. Genetic and neural predictors of behavioral weight loss treatment: a preliminary study. Obesity. 2017;25(1):66–75.
  • McCoy M. Evaluation of a standardized wellness protocol to improve anthropometric and physiologic function and to reduce health risk factors: a retrospective analysis of outcome. J Altern Complement Med. 2011;17(1):39–44.
  • Mitchell NS, Dickinson LM, Kempe A, et al. Determining the effectiveness of Take Off Pounds Sensibly (TOPS), a nationally available nonprofit weight loss program. Obesity (Silver Spring). 2011;19(3):568–573.
  • Mitchell NS, Polsky S, Catenacci VA, et al. Up to 7 Years of Sustained Weight Loss for Weight-Loss Program Completers. Am J Prev Med. 2015;49(2):248–258.
  • Bischoff SC, Damms-Machado A, Betz C, et al. Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life–a prospective study. Int J Obes (Lond). 2012;36(4):614–624.
  • Muramoto A, Matsushita M, Kato A, et al. Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan. Obes Res Clin Pract. 2014;8(5):e466–e475.
  • Rothberg AE, McEwen LN, Kraftson AT, et al. Very-low-energy diet for type 2 diabetes: an underutilized therapy? J Diabetes Complications. 2014;28(4):506–510.
  • Li Z, Hong K, Wong E, et al. Weight cycling in a very low-calorie diet programme has no effect on weight loss velocity, blood pressure and serum lipid profile. Diabetes Obes Metab. 2007;9(3):379–385.
  • Schutte BA, Haveman-Nies A, One-Year PL. Results of the BeweegKuur lifestyle intervention implemented in Dutch primary healthcare settings. Biomed Res Int. 2015;2015:484823.
  • Painter S, Ditsch G, Ahmed R, et al. Retrofit weight-loss outcomes at 6, 12, and 24 months and characteristics of 12-month high performers: a retrospective analysis. JMIR Mhealth Uhealth. 2016;4(3):e101.
  • Painter SL, Ahmed R, Hill JO, et al. What matters in weight loss? An in-depth analysis of self-monitoring. J Med Internet Res. 2017;19(5):e160.
  • Goodrich DE, Klingaman EA, Verchinina L, et al. Sex differences in weight loss among veterans with serious mental illness: observational study of a national weight management program. Womens Health Issues. 2016;26(4):410–419.
  • Ahrendt AD, Kattelmann KK, Rector TS, et al. The effectiveness of telemedicine for weight management in the MOVE! Program. J Rural Health. 2014;30(1):113–119.
  • Braun K, Erickson M, Utech A, et al. Evaluation of veterans MOVE! Program for weight loss. J Nutr Educ Behav. 2016;48(5):299–303.e1.
  • Chan SH, Raffa SD. Examining the dose-response relationship in the Veterans Health Administration’s MOVE!(R) Weight Management Program: a nationwide observational study. J Gen Intern Med. 2017;32(Suppl1):18–23.
  • Tan WJ, Wong TK. Demographic profile, clinical characteristics, motivations and weight loss outcomes of patients in a nonsurgical weight management programme. Singapore Med J. 2014;55(3):150–154.
  • Jackson SL, Long Q, Rhee MK, et al. Weight loss and incidence of diabetes with the Veterans Health Administration MOVE! lifestyle change programme: an observational study. Lancet Diabetes Endocrinol. 2015;3(3):173–180.
  • Thomas EA, McNair B, Bechtell JL, et al. Greater hunger and less restraint predict weight loss success with phentermine treatment. Obesity (Silver Spring). 2016;24(1):37–43.
  • Elfhag K, Finer N, Rossner S. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. Diabetes Obes Metab. 2008;10(6):498–505.
  • Sumithran P, Prendergast LA, Haywood CJ, et al. Review of 3-year outcomes of a very-low-energy diet-based outpatient obesity treatment programme. Clin Obes. 2016;6(2):101–107.
  • Meridia (sibutramine hydrochloride monohydrate) [package insert]. North Chicago, IL: Abbott Laboratories; 2009.
  • ADIPEX-P (phentermizne hydrochloride USP) [package insert]. Sellersville, PA: Teva Pharmaceuticals; 2012.
  • Topamax (topiramate) [package insert]. Gurabo, Puerto Rico: Janssen Ortho, LLC; 2012.
  • Qsymia (phentermine and topiramate extended-release) [package insert]. Campbell, CA: Vivus Medical; 2012.
  • Byetta (exenatide) [package insert]. San Diego, CA: Amylin Pharmaceuticals, Inc; 2009.
  • United States Food and Drug Administration. FDA drug safety communication: FDA recommends against the Continued use of Meridia® (sibutramine). 2010 Oct 8. Available from: https://www.fda.gov/Drugs/DrugSafety/ucm228746.htm (Accessed 2017 Jun 8).
  • Contrave (naltrexone HCl and bupropion HCl) [package insert]. Deerfield, IL: Takeda Pharmaceuticals America, Inc; 2014.
  • Belviq (lorcaserin hydrochloride) [package insert]. Zofingen, Switzerland: Arena Pharmaceuticals GmbH; 2017.
  • Saxenda (liraglutide [rDNA origin] injection) [package insert]. Bagsvaerd, Denmark: Novo Nordisk A/S; 2014.
  • Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrin Metab. 2015;100(2):342–362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.